AZACITIDIN Accord subst seche 150 mg 1 pce

7680667700029 CH-66770 L01BC07 07.16.1.

Active substances:

Azacitidinum

No images available

Details

Product number
6677002
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
azacitidinum 150 mg, mannitolum, pro vitro.

Articles (1)

Azacitidin Accord 150 mg, Pulver zur Herstellung einer Injektionssuspension
Pulver zur Herstellung einer Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
11/05/2026
Professional SmPC
Français
11/05/2026
Professional SmPC
Italien
11/05/2026

Detailed composition

Substance Quantity Type Category
azacitidinum
150.0 MG Substance Wirkstoff (Principe actif)
mannitolum
- Substance HNIDK

Reimbursement information

Public price
CHF 356.65
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2026

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
66770
Drug name
Azacitidin Accord, Pulver zur Herstellung einer Injektionssuspension
Galenic form
PULPA
ATC Code
L01BC07
Authorization status
Z
Dispensation category
A
First authorization
28/11/2018
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Packaging details

Description (FR)
AZACITIDIN Accord subst seche 150 mg 1 pce
Description (DE)
AZACITIDIN Accord Trockensub 150 mg 1 Stk
Market launch
01/07/2026
Narcotic (BTM)
No

Original drug

Vidaza, Lyophilisat zur Herstellung einer Injektionssuspension
GTIN: 7680573800011
CHF 350.75
View original

Other packaging sizes

AZACITIDIN Accord subst seche 100 mg 1 pce
1 DUR
GTIN: 7680667700012
View
Buy us a coffee Explore the data